申请人:Mylan Pharmaceuticals, Inc.
公开号:EP0100061A2
公开(公告)日:1984-02-08
A novel combination pharmaceutical composition is described, together with a method for making the same, wherein the pharmaceutically active ingredients are separately milled and then formed into separate granules, and only thereafter blended together to form the combination composition. The method for achieving this novel combination composition is also described. In particular, a novel combination composition of triamterene and hydrochlorothiazide having improved bioavialability and novel effectiveness to prevent or eliminate hypokalemic side effects is also described.
本文描述了一种新型组合药物组合物,以及制造这种组合物的方法,其中药用活性成分被分别碾磨,然后制成单独的颗粒,之后才混合在一起形成组合物。此外,还介绍了实现这种新型组合物的方法。特别是,还描述了一种新型的三苯氧胺和氢氯噻嗪组合物,该组合物具有更好的生物可吸收性和新的功效,可防止或消除低钾血症副作用。